Beauty Health (NASDAQ:SKIN) Upgraded to Hold at Zacks Research

Zacks Research upgraded shares of Beauty Health (NASDAQ:SKIN) from a strong sell rating to a hold rating in a report released on Monday morning,Zacks.com reports.

Several other analysts have also weighed in on the company. Jefferies Financial Group restated a “hold” rating and issued a $1.60 price objective on shares of Beauty Health in a report on Wednesday, January 14th. TD Cowen lowered their target price on Beauty Health from $1.65 to $1.50 and set a “hold” rating on the stock in a report on Monday. Benchmark reiterated a “hold” rating on shares of Beauty Health in a research report on Friday, March 13th. Finally, Canaccord Genuity Group reissued a “hold” rating and issued a $1.50 price target on shares of Beauty Health in a report on Friday, March 13th. One research analyst has rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average target price of $2.42.

Beauty Health Price Performance

Shares of NASDAQ:SKIN opened at $1.18 on Monday. The stock has a market cap of $150.45 million, a price-to-earnings ratio of -5.90 and a beta of 1.20. The company has a debt-to-equity ratio of 3.94, a current ratio of 1.66 and a quick ratio of 1.40. Beauty Health has a 12 month low of $0.78 and a 12 month high of $2.69. The stock’s 50 day moving average price is $1.25 and its 200 day moving average price is $1.50.

Beauty Health (NASDAQ:SKIN) last issued its quarterly earnings results on Thursday, March 12th. The company reported ($0.06) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.01. Beauty Health had a negative return on equity of 15.40% and a negative net margin of 3.16%.The firm had revenue of $82.37 million during the quarter, compared to analyst estimates of $78.07 million. Equities research analysts anticipate that Beauty Health will post -0.25 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Beauty Health

Several large investors have recently modified their holdings of SKIN. Woodline Partners LP boosted its stake in shares of Beauty Health by 255.9% during the 3rd quarter. Woodline Partners LP now owns 5,930,027 shares of the company’s stock worth $11,801,000 after acquiring an additional 4,263,997 shares in the last quarter. Millennium Management LLC raised its position in shares of Beauty Health by 127.0% during the fourth quarter. Millennium Management LLC now owns 5,764,802 shares of the company’s stock worth $8,013,000 after purchasing an additional 3,225,668 shares during the period. Mirabella Financial Services LLP lifted its holdings in shares of Beauty Health by 21.3% during the third quarter. Mirabella Financial Services LLP now owns 15,596,277 shares of the company’s stock valued at $31,037,000 after purchasing an additional 2,734,728 shares during the last quarter. Soleus Capital Management L.P. purchased a new stake in shares of Beauty Health during the second quarter valued at $1,910,000. Finally, Geode Capital Management LLC boosted its position in shares of Beauty Health by 27.5% in the 2nd quarter. Geode Capital Management LLC now owns 2,302,784 shares of the company’s stock valued at $4,399,000 after purchasing an additional 496,963 shares during the period. 93.26% of the stock is owned by institutional investors.

Beauty Health Company Profile

Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.